4502 vs 9SO: Side-by-Side Comparison
Compare Takeda Pharmaceutical Company Limited (4502) and Solasia Pharma K.K (9SO) side by side: market cap JPY 8.14T vs EUR 30.03M. Financials, growth and model signals on Bullrun.
| Metric | 4502 | 9SO |
|---|---|---|
| Company | Takeda Pharmaceutical Company Limited | Solasia Pharma K.K |
| Country / Exchange | Japan · TSE | Japan · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | JPY 8.14T | EUR 30.03M |
| P/E ratio | — | — |
| Dividend yield | 3.94% | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | EUR 429.00M |
| Revenue growth YoY | — | +35.8% |
| Net income | — | EUR -876.00M |
| Gross margin | — | 48.3% |
| Diluted EPS | — | — |